Ratings by CCB Int'l
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 9/18/2026 | N/A | Neurocrine Bio. | NBIX | New Coverage | Outperform (N/A) |
N/A (N/A) |
151.83 (143.04) |
-5.79% | Details |
| 1/28/2026 | N/A | Futu Holdings Limited | FUTU | New Coverage | Outperform (N/A) |
250.00 (N/A) |
163.04 (114.34) |
-29.87% | Details |
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
| 18 more... | |||||||||


